|
|||||
|
|
A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study |
|
| Authors: | James V. Fiorica John A. Blessing Louis V. Puneky Angeles Alvarez Secord James S. Hoffman S. Diane Yamada Thomas E. Buekers Jeffrey Bell Jeanne M. Schilder |
| Abstract: | |
| Keywords: | Topotecan hydrochloride Advanced and recurrent cervical cancer |
| 本文献已被 ScienceDirect 等数据库收录！ | |